Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT—Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment
Recently, a variety of physiologically based pharmacokinetic (PBPK) models have been developed for the essential element manganese. This paper reviews the development of PBPK models (e.g., adult, pregnant, lactating, and neonatal rats, nonhuman primates, and adult, pregnant, lactating, and neonatal...
Saved in:
Main Authors: | Michael D. Taylor, Harvey J. Clewell, Melvin E. Andersen, Jeffry D. Schroeter, Miyoung Yoon, Athena M. Keene, David C. Dorman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Toxicology |
Online Access: | http://dx.doi.org/10.1155/2012/791431 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A physiologically-based pharmacokinetic model for the antibiotic ertapenem
by: Michele L. Joyner, et al.
Published: (2015-09-01) -
Surface Properties of Manganese(II) Carbonate
by: Nikolai V. Nikolenko, et al.
Published: (2002-07-01) -
Application of Physiologically Based Pharmacokinetic Models in Chemical Risk Assessment
by: Moiz Mumtaz, et al.
Published: (2012-01-01) -
The Use of Spreadsheets for Pharmacokinetic Simulations
by: Joseph Chamberlain
Published: (2003-01-01) -
Pharmacokinetic and pharmacodynamic data analysis : concepts and applications /
by: Gabrielsson, Johan
Published: (2016)